UroGen Pharma Ltd. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $5.90 | $320.64 M | -1.97 | 145 | $20.76 M |
 CELC
|
Celcuity Inc. | $14.40 | $501.59 M | -5.14 | 55 | $0 |
 CMPX
|
Compass Therapeutics, Inc. | $1.88 | $180.24 M | -3.74 | 32 | $0 |
 CNTB
|
Connect Biopharma Holdings Limited | $1.35 | $108.00 M | -1.81 | 81 | $0 |
 ELVN
|
Enliven Therapeutics, Inc. | $24.11 | $984.95 M | -11.97 | 52 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $4.97 | $258.33 M | -17.08 | 9 | $0 |
 ERAS
|
Erasca, Inc. | $2.68 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 GBIO
|
Generation Bio Co. | $2.40 | $216.88 M | -1.28 | 174 | $5.90 M |
 IKNA
|
Ikena Oncology, Inc. | $1.71 | $84.45 M | -1.11 | 18 | $9.16 M |
 INBX
|
Inhibrx Biosciences, Inc. | $15.55 | $241.02 M | -1.44 | 166 | $1.80 M |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 MACK
|
Merrimack Pharmaceuticals, Inc. | $15.15 | $223.75 M | -168.11 | 0 | $0 |
 OVID
|
Ovid Therapeutics Inc. | $1.18 | $210.00 M | -4.11 | 40 | $391,695 |
 PEPG
|
PepGen Inc. | $8.79 | $537.15 M | -5.11 | 72 | $0 |
 PRTC
|
PureTech Health plc | $21.25 | $809.08 M | -12.47 | 90 | $3.33 M |
 SRRK
|
Scholar Rock Holding Corporation | $8.74 | $758.46 M | -4.55 | 150 | $0 |
 TARA
|
Protara Therapeutics, Inc. | $1.88 | $54.98 M | -0.71 | 26 | $0 |
 TYRA
|
Tyra Biosciences, Inc. | $23.30 | $1.04 B | -11.7 | 49 | $0 |
 VACC
|
Vaccitech plc | $5.00 | $192.73 M | -3.45 | 33 | $44.70 M |
 VIGL
|
Vigil Neuroscience, Inc. | $3.31 | $172.89 M | -2.17 | 64 | $0 |
 XLO
|
Xilio Therapeutics, Inc. | $0.76 | $38.76 M | -0.41 | 73 | $0 |